| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Seres Therapeutics, Inc. | EVP, Chief Commercial & Strategy Officer | Common Stock | 90.4K | $48.9K | $0.54 | Nov 18, 2024 | Direct |
| Seres Therapeutics, Inc. | EVP, Chief Commercial & Strategy Officer | Restricted Stock Units | 23.9K | $12.9K | $0.54 | Nov 15, 2024 | Direct |
| Seres Therapeutics, Inc. | EVP, Chief Commercial & Strategy Officer | Stock Option (Right to Buy) | 288K | Feb 14, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | Nov 15, 2024 | 3 | -$398 | 4 | Nov 19, 2024 | EVP, Chief Commercial & Strategy Officer |
| MCRB | Seres Therapeutics, Inc. | Oct 27, 2024 | 3 | -$2.06K | 4 | Oct 29, 2024 | EVP, Chief Commercial & Strategy Officer |
| MCRB | Seres Therapeutics, Inc. | Aug 15, 2024 | 3 | -$612 | 4 | Aug 19, 2024 | EVP, Chief Commercial & Strategy Officer |
| MCRB | Seres Therapeutics, Inc. | Aug 3, 2024 | 3 | -$26.5K | 4 | Aug 6, 2024 | EVP, Chief Commercial & Strategy Officer |
| MCRB | Seres Therapeutics, Inc. | May 15, 2024 | 3 | -$661 | 4 | May 17, 2024 | EVP, Chief Commercial & Strategy Officer |
| MCRB | Seres Therapeutics, Inc. | Feb 14, 2024 | 6 | -$3.64K | 4 | Feb 16, 2024 | EVP, Chief Commercial & Strategy Officer |
| MCRB | Seres Therapeutics, Inc. | Oct 27, 2023 | 4 | -$3.92K | 4 | Oct 31, 2023 | EVP, Chief Commercial & Strategy Officer |
| MCRB | Seres Therapeutics, Inc. | Feb 3, 2023 | 3 | $0 | 4 | Feb 7, 2023 | EVP, Chief Commercial & Strategy Officer |
| MCRB | Seres Therapeutics, Inc. | Feb 4, 2022 | 1 | $0 | 4 | Feb 8, 2022 | EVP, Chief Commercial & Strategy Officer |